[1]
|
World Health Organization (WHO 2008), “The Global Burden of Disease,” 2004 Update.
|
[2]
|
H. Rochefort and J. Rou?ssé, “Breast Cancer: Incidence and Prevention,” Report of a Working Group of Committee III (Cancer), 2000, p. 22.
|
[3]
|
I. Diomandé, A. F. D’Horpock, P. Heroin, M. Ette, A. Dago, F. Battesti, et al., “EVol.ution of Cancer in Ivory Coast,” Medical Publication in Ivory Coast, Vol. 75, 1988, pp. 81-84.
|
[4]
|
A. Echimane, A. Ahnoux, I. Adoubi, S. Hien, K. M’Bra, A. F. D’Horpock, et al., “Cancer Incidence in Abidjan, Ivory Coast. First Results from the Cancer Registry, 1995-1997,” Cancer, Vol. 89, No. 3, 2000, pp. 653-663. doi:10.1002/1097-0142(20000801)89:3<653::AID-CNCR22>3.0.CO;2-Z
|
[5]
|
M. Traore, F. S. Diabate, I. Diarra, N. Mounkoro, Y. Traore, I. Tekété, et al., “Breast and Gynecologic Cancer at the Hospital from the Point G in Bamako,” Medical Publication in Mali, Vol. 19, No. 2, 2004, pp. 4-9.
|
[6]
|
D. Sano, R. Cissé, B. Dao, J. Lankoandé, S. S. Traore, R. B. Soudré, et al., “Breast Cancer, Diagnostic and Therapeutic Problems at the Hospital of Ouagadougou,” Medical Publication in Subsaharan Africa, Vol. 45, No. 5, 1998, pp. 297-301.
|
[7]
|
H. Najjar and A. Easson, “Age at Diagnosis of Breast Cancer in Arab Nations,” International Journal of Surgery, 2010, [Epub ahead of print].
|
[8]
|
C. R. Raharisolo Vol.olonantenaina, L. P. Rabarijiaona, C. Rajemiarimoeisoa, M. Rasendramino and R. Migliani, “Assessment of Breast Cancers Diagnosed L’institut Pasteur de Madagascar from 1995 to 2001,” Archives de L’Institut Pasteur de Madagascar, Vol. 68, 2002, pp. 104-108.
|
[9]
|
D. Shaheenah, B. Kristine, A. Gonzalez, A. U. Busdor, N. Hortobagyi and H. G. Sharon, “Trends in Survival over the Past Two Decades among White in Black Patients with Newly Diagnosed Internship IV Breast Cancer,” Journal of Clinical Oncology, Vol. 26, 30, 2008, pp. 4889-4899.
|
[10]
|
C. A. Adebamowo, S. N. Akarolo-Anthony and O. O. Temiayo, “Emerging Epidermic Breast Cancer: Evidence from Africa,” Breast Cancer Research, Vol. 12, Supp. l 4, 2010, S8. doi:10.1186/bcr2737
|
[11]
|
A. Antoniou, P. D. Pharoah, S. Narod, H. A. Risch, J. E. Eyfjord, J. L. Hopper, et al., “Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies,” Erratum in: The American Journal of Human Genetics, Vol. 73, No. 3, 2003, p. 709.
|
[12]
|
C. M. Friedenreich and M. R. Orenstein, “Physical Activity and Cancer Prevention: Etiologic Evidence and Biological Mechanisms,” Journal of Nutrition, Vol. 132, No. 11, 2002, 3456S-3664S.
|
[13]
|
World Health Organization, “Tumors of the Breast and the Female Genital Organs,” In: P. Deviled, Ed., Pathology and Genetics, IARC Press, Lyon, 2003, pp. 13-59.
|
[14]
|
A. Laplanche and E. Benhamou, “Estimated incidence of Cancer in France,” Bull Cancer, Vol. 78, No. 5, 1991, pp. 505-514.
|
[15]
|
E. Duarte-Franco and E. L. Franco, “Others Gynecologic Cancers: Endometrial, Ovarian, and Vaginal Cancers Vulva,” BMC Women’s Health, Vol. 25, Suppl. 1, 2004, p. S14. doi:10.1186/1472-6874-4-S1-S14
|
[16]
|
D. M. Parkin, S. L. Whelan, J. Ferlay, L. Raymond and J. Young, “Cancer in Five Continents,” IARC Scientific Publications, Lyon, Vol. 12, No. 143, 1997, pp. 35-36.
|
[17]
|
A. B. Effi, K. J. N’Dah, A. A. N’Guiessan, B. Doukouré, M. Kouyaté, A. D. Abouna, et al., “Epidemiology and Pathology of Carcinoma in Ivory Coast,” African Journal of Cancer, Vol. 4, 2012, pp. 41-47. doi:10.1007/s12558-011-0189-2
|